-+ 0.00%
-+ 0.00%
-+ 0.00%

Dermata Therapeutics Q3 EPS $(0.55), Inline

Benzinga·11/10/2026 21:25:00
Listen to the news
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(0.55) per share which met the analyst consensus estimate. This is a 66.67 percent increase over losses of $(1.65) per share from the same period last year.